Page last updated: 2024-10-26

etidronate and Sjogren's Syndrome

etidronate has been researched along with Sjogren's Syndrome in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"By 24 months, renal tubular acidosis was improved and the bone density had normalized."1.39Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome. ( Hirata, S; Inokuchi, N; Mori, H; Okada, Y; Saito, K; Tanaka, Y; Yamamoto, S, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vestergaard, P1
Schwartz, K1
Rejnmark, L1
Mosekilde, L1
Pinholt, EM1
Yamamoto, S1
Okada, Y1
Mori, H1
Hirata, S1
Saito, K1
Inokuchi, N1
Tanaka, Y1

Other Studies

2 other studies available for etidronate and Sjogren's Syndrome

ArticleYear
Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:4

    Topics: Administration, Oral; Aged; Alcoholism; Alendronate; Bisphosphonate-Associated Osteonecrosis of the

2012
Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome.
    Modern rheumatology, 2013, Volume: 23, Issue:2

    Topics: Acidosis, Renal Tubular; Bone Density Conservation Agents; Drug Therapy, Combination; Etidronic Acid

2013